Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SJL-TF is a botanical extract consisting of the total flavonoids derived from the leaves of the sour jujube (Ziziphus acidojujuba). It is typically produced using ultrasound-assisted extraction and purified via polyamide resin chromatography. The extract is a complex mixture containing at least ten major flavonoids: catechin, rutin, isoquercetin, narirutin, nicotiflorin, quercitrin, phlorizin, luteolin, quercetin, and apigenin. SJL-TF has demonstrated significant anti-inflammatory and protective effects in preclinical models of dextran sulfate sodium (DSS)-induced ulcerative colitis, where it reduces colonic inflammation and pathological damage. It is being explored for potential pharmaceutical applications in treating inflammatory bowel diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sour jujube leaves total flavonoids.